Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,253 | 59,444 | 58,311 | 96,709 | 42,326 |
| Marketable Securities | 136,631 | 156,969 | 179,630 | 130,005 | 206,803 |
| Receivables | 203 | 1,230 | 3,590 | 3,315 | 3,055 |
| TOTAL | $221,634 | $224,493 | $246,387 | $235,088 | $256,752 |
| Non-Current Assets | |||||
| PPE Net | 1,493 | 1,600 | 1,904 | 2,063 | 1,780 |
| Intangibles | 41,638 | 41,638 | 41,638 | 41,638 | 41,638 |
| Other Non-Current Assets | 14,138 | 15,523 | 16,377 | 16,012 | 13,140 |
| TOTAL | $57,269 | $58,761 | $59,919 | $59,713 | $56,558 |
| Total Assets | $278,903 | $283,254 | $306,306 | $294,801 | $313,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,562 | 4,598 | 1,611 | 3,640 | 2,104 |
| Accrued Expenses | 8,001 | 16,431 | 11,855 | 10,381 | 9,063 |
| TOTAL | $14,497 | $24,433 | $16,804 | $17,271 | $21,146 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 6,715 |
| Other Non-Current Liabilities | 5,644 | 6,725 | 7,435 | 7,884 | 8,539 |
| TOTAL | $17,162 | $18,243 | $18,953 | $10,415 | $40,396 |
| Total Liabilities | $31,659 | $42,676 | $35,757 | $27,686 | $61,542 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,345 | 3,186 | 2,751 | 2,737 | 2,726 |
| Common Shares | 40 | 34 | 33 | 33 | 32 |
| Retained earnings | -528,773 | -501,573 | -462,155 | -458,806 | -466,076 |
| Other shareholders' equity | -271 | -270 | -158 | 104 | -86 |
| TOTAL | $247,244 | $240,578 | $270,549 | $267,115 | $251,768 |
| Total Liabilities And Equity | $278,903 | $283,254 | $306,306 | $294,801 | $313,310 |